Blog

After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.Read all about it on the C...

In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA testing and has been approved by the US FDA for WNV, ZIKA, and now Ultrio Elite testing. The Procleix Panther instrument with its automated process will allow the CTS laboratories to operate with increased efficiencies with processing all three assays (WNV, ZIKA, Ultrio Elite) using a single pooled or individual donation sample. We expect less downtime and fewer NAT assay failures. On Tu...

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.Thanks for your support as we work to rapidly get this testing available to you. &nbs...

CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: